AbbVie Inc., (NYSE:ABBV) a leading healthcare entity listed on S&P 500 Chart index, recently saw a shift in institutional ...

AbbVie Inc. (NYSE:ABBV) and the Chicago Cubs have announced a major multi-year partnership to fight cancer, launching the ...

On May 14, the U.S. Food and Drug Administration (FDA) granted accelerated approval to AbbVie's Emrelis (telisotuzumab ...

The recent jobs data showed that hiring in healthcare took a big jump in May, as the stock sector has stabilized a bit after ...

Over the last 7 days, the United States market has risen by 2.0% and is up 12% over the past year, with earnings forecasted to grow by 14% annually. In such a dynamic environment, identifying high ...

Novo Nordisk announces that CVS Caremark®, the country's largest PBM, has decided Wegovy® will be the preferred GLP-1 ...

The large molecule injectable drugs market is anticipated to expand at a CAGR of ~9% during the forecast period. Key drivers ...

For the quarter, the Voya Corporates Leaders Trust Fund Series B outperformed its benchmark, the S&P 500 Index on a net asset ...

The global immuno-oncology market is set to witness a growth rate of 21% in the next 5 years. Increasing incidence and ...

Launched on 01/26/2004, the Vanguard Health Care ETF (VHT) is a passively managed exchange traded fund designed to provide a broad exposure to the Healthcare - Broad segment of the equity market.

The Newport Beach aesthetics company launched Evolysse Form and Evolysse Smooth, which refers to its injectable hyaluronic ...

Most Dividend Kings are currently overpriced, but six offer fair value with high dividend yields. Read more about top picks ...